Table 4 Multivariable linear regression analyses demonstrating relationships of cholesterol efflux with glucose metabolism status (normal glucose metabolism [NGM], impaired glucose metabolism [IGM] and Type 2 diabetes mellitus [T2DM]) and metabolic syndrome (MetS) in 552 subjects.

From: Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study

 

Model 1

Model 2

β

P-value

β

P-value

Age

0.047

0.27

0.044

0.32

Sex (men vs. women)

−0.124

0.003

−0.168

<0.001

Glucose tolerance category

 IGM vs. NGM

0.037

0.43

0.026

0.57

 T2DM vs. NGM

0.019

0.70

0.022

0.71

MetS (yes/no)

−0.169

<0.001

−0.150

0.002

  1. β: standardized regression coefficient.
  2. Model 1: adjusted for age and sex.
  3. Model 2: additionally adjusted for current smoking, alcohol consumption, cardiovascular disease, glucose lowering drugs, lipid modifying drugs and antihypertensive medication.